Target intelligence / Profile preview

Poliovirus D-antigen

Molecular classification
Other (Viral conformational antigen)
01

Overview

The Poliovirus D-antigen refers to the specific native, conformational antigenic form of the poliovirus capsid present in all three serotypes of poliovirus (types 1, 2, and 3). This structure is associated with the mature, infectious virus and is distinguished from the C-antigen, a non-native, altered form, which does not elicit enduring immune protection. The D-antigen consists of multiple conformational epitopes on the capsid surface, with at least four distinct antigenic sites, and is the form responsible for inducing protective, virus-neutralizing antibodies following immunization[2][3][4][5]. The content of D-antigen in poliovirus vaccines is critical for vaccine effectiveness, and its quantification is a standard measure for vaccine potency. Loss or denaturation of the D-antigen, such as through heat or improper vaccine processing, results in reduced immunogenicity. The D-antigen is not a molecular target for drugs (e.g., it is not a receptor or enzyme); instead, it is a structural configuration of the viral particle essential for effective vaccination and immune protection[2][3][4][5].

Other names
Poliovirus D antigenPV D-antigen
02

Biological functions

Induces protective antibody responseVaccine immunogen
03

Disease associations

Infection (Poliovirus, Poliomyelitis)
04

Safety considerations

Loss or conversion of D-antigen into the non-immunogenic C-antigen reduces vaccine efficacy[5]
05

Biomarkers

D-antigen quantity is a biomarker for effective inactivated polio vaccine potency[2][3][4][5]

Beyond the preview

Go deeper on Poliovirus D-antigen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Poliovirus D-antigen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call